Compassionate drug use is though the ultimate alternative suggested by the health experts to treat the diseases; It has many difficulties bumped in it. The starting block to use the compassionate drugs is its availability. Though the clinical trials are the easiest doors to fetch the desired, there are many issues like eligibility criteria to get the compassionate drug. As the drug is clinically un approved, many approvals from the regulatory authorities becomes the major blocks.
You will have the chances of getting the drug through the expanded accesses or single-patient compassionate use. The benefits offered by the single-patient compassionate use does not outweigh the frustration involved in handling the process. No FDA drug company will encourage single policy or process because providing the excess accessibility of the drug to the patients out of the clinical trial will be an expensive affair. They fallow the practice to make the best utilization of limited amount of drugs and reduce the chances of disapproval.
No comments:
Post a Comment